PPT-CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE

ASSOC PROF DR INGRID MIRON What is Viral Hepatitis Viral hepatitis is a systemic disease with primary inflammation of the liver by any one of a heterogenous group of hepatotropic viruses. -FULMINANT HEPATIC FAILURE-................AETIOLOGY ................................................................................................................................................. KNH 411. Morgan . Deihs. Lydia Dysart. Objectives. Define Cirrhosis . Understand what MELD means. Name 3 SYMPTOMS of Cirrhosis. Name 3 Methods of TREATMENT for Cirrhosis. Background. Teresa (Terri) Wilcox:. Patrick Fleming, MD. Henry Ford EM; PGY-3. Goals and Objectives. Review definition/classification of hepatic encephalopathy (HE) and its pathophysiology. Review differential diagnosis, clinical/laboratory findings, and management of HE. By: Michelle Russell. Case Study Presentation. NUR 4216L. 12-4-12. 1. Objectives. Understand the . pathophysiology. of hepatic encephalopathy. Recogonize. the signs/ symptoms. Understand relevance to clinical setting and patient scenarios. Assistant . Professor of Medicine. Division of Gastroenterology and Hepatology. University . of Washington. Hepatic Encephalopathy. Last . Updated: . August 21, 2013. Disclosure Slide. Dr. Landis receives research support from the following:. Barb Bancroft, RN, MSN, PNP. BBancr9271@aol.com. www.barbbancroft.com. Just the facts…. The adult liver is the size of a football and weighs approximately 4 lbs. . 2. nd. largest organ (skin is #1). Diagnostic and clinical manifestations. Hepatic disorders. Pancreatic disorders. The nursing processes. Functions of the liver. It receives nutrients-rich blood from GIT. It stores, transforms these nutrients into chemicals to be used by the body. primary. diseases of the liver are:. - Viral hepatitis, . - Nonalcoholic fatty liver disease (NAFLD), . - Alcoholic liver disease, . - Hepatocellular carcinoma (HCC). Hepatic damage also occurs . secondary . Kings College Hospital London UK. . 20–50%. . <1.0%. . 2–3%. . 7–8%. . 3–5%. . 2–6% for HBeAg+. . 20–50%. <0.2%. . 8–10% for HBeAg-. HBV-related liver disease progression. . FMC. Disclosures. nil. Learning objectives/. t. alk plan. Epidemiology and natural history of HCV infection in Australia. Who is at high risk for HCV and how to screen. How to evaluate patient with HCV. TREATMENT . Dr. . Vikram. . Chauhan. is One of the most . Promising . Ayurvedic. doctors in the world. and a senior consultant physician from India. . He has 12 years of international exposure & . Condition. National Notification Criteria*. Print Criteria†. Hepatitis. . A. Confirmed. Confirmed. Acute . hepatitis. . B. Confirmed. Confirmed. Chronic . hepatitis. . B. Confirmed. . and. . probable. DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA. . DR. R MANE. TOPICS DISCUSSED : . Hepatic encephalopathy. Spontaneous bacterial peritonitis. Hepatorenal. syndrome. Hepatopulmonary. syndrome. Chris Kolkman. PrimaryOne. Health. Meet MM. Patient Background. MM is a 59-year-old Hispanic female who presents for a regular health checkup, accompanied by her daughter to help translate. . CC: “I would like to establish care here in the US and to have someone manage my diabetes and cirrhosis.”.